[1]
Carpenedo, M. et al. 2023. Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists. Mediterranean Journal of Hematology and Infectious Diseases. 15, 1 (Feb. 2023), e2023021. DOI:https://doi.org/10.4084/MJHID.2023.021.